A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naïve people with type 2 diabetes. - Hermansen,K.; Davies,M.; Derezinski,T. (Diabetes Care, 2006)